Feb 4, 2025 • 7:30 AM EST XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Dec 2, 2024 • 7:30 AM EST XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
Recent Event Feb 11, 2025 • 3:20 pm EST Oppenheimer 35th Annual Healthcare Life Sciences Conference View Event View All
